Effects of melanocortins on adrenal gland physiology

European Journal of Pharmacology

Volumn 660, Issue 1, 2011, Pages 171-180

  Chan, Li F ^a   Metherell, Louise A ^a   Clark, Adrian J L ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Accessory protein; Adrenal gland; Melanocortin receptor

Indexed keywords

ALDOSTERONE; ALPHA INTERMEDIN; CORTICOTROPIN; CYCLIC AMP; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR; PRASTERONE; PRASTERONE SULFATE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ADRENAL GLAND; DNA SEQUENCE; GENE MUTATION; GLUCOCORTICOSTEROID DEFICIENCY; HOMOZYGOSITY; HORMONE DEFICIENCY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STEROIDOGENESIS;

ADRENAL GLANDS; ANIMALS; CARRIER PROTEINS; HUMANS; MELANOCORTINS; MEMBRANE PROTEINS; RECEPTOR, MELANOCORTIN, TYPE 2;

EID: 79955931115     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.11.041     Document Type: Review

References (94)

1. Agulleiro, M.J., Roy, S., Sanchez, E., Puchol, S., Gallo-Payet, N., Cerda-Reverter, J.M., 2010. Role of melanocortin receptor accessory proteins in the function of zebrafish melanocortin receptor type 2. Mol. Cell. Endocrinol. 320, 145-152.
2. Arnaldi, G., Mancini, V., Costantini, C., Giovagnetti, M., Petrelli, M., Masini, A., Bertagna, X., Mantero, F., 1998. ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas. Endocr. Res. 24, 845-849.
3. Balthasar, N., Dalgaard, L.T., Lee, C.E., Yu, J., Funahashi, H., Williams, T., Ferreira, M., Tang, V., McGovern, R.A., Kenny, C.D., Christiansen, L.M., Edelstein, E., Choi, B., Boss, O., Aschkenasi, C., Zhang, C.Y., Mountjoy, K., Kishi, T., Elmquist, J.K., Lowell, B.B., 2005. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123, 493-505. (Pubitemid 41546678)
4. Bicknell, A.B., Lomthaisong, K., Woods, R.J., Hutchinson, E.G., Bennett, H.P., Gladwell, R.T., Lowry, P.J., 2001. Characterization of a serine protease that cleaves progamma-melanotropin at the adrenal to stimulate growth. Cell 105, 903-912. (Pubitemid 32635091)
5. Boscaro, M., Sonino, N., Paoletta, A., Rampazzo, A., Mantero, F., 1988. Evidence for ultrashort loop autoregulation of adrenocorticotropin secretion inman. J. Clin. Endocrinol. Metab. 66, 255-257.
6. Boston, B.A., Cone, R.D., 1996. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 137, 2043-2050. (Pubitemid 26139698)
7. Chan, L.F., Metherell, L.A., Krude, H., Ball, C., O'Riordan, S.M., Costigan, C., Lynch, S.A., Savage, M.O., Cavarzere, P., Clark, A.J., 2009a. Homozygous nonsense and frameshift mutations of the ACTH receptor in children with familial glucocorticoid deficiency (FGD) are not associated with long-term mineralocorticoid deficiency. Clin. Endocrinol. (Oxf) 71, 171-175.
8. Chan, L.F., Webb, T.R., Chung, T.T., Meimaridou, E., Cooray, S.N., Guasti, L., Chapple, J.P., Egertova, M., Elphick, M.R., Cheetham, M.E., Metherell, L.A., Clark, A.J., 2009b. MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proc. Natl Acad. Sci. USA 106, 6146-6151.
9. Chen, W., Kelly, M.A., Opitz-Araya, X., Thomas, R.E., Low, M.J., Cone, R.D., 1997. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91, 789-798. (Pubitemid 28007735)
10. Chen, A.S., Marsh, D.J., Trumbauer, M.E., Frazier, E.G., Guan, X.M., Yu, H., Rosenblum, C.I., Vongs, A., Feng, Y., Cao, L., Metzger, J.M., Strack, A.M., Camacho, R.E., Mellin, T.N., Nunes, C.N., Min, W., Fisher, J., Gopal-Truter, S., MacIntyre, D.E., Chen, H.Y., Van der Ploeg, L.H., 2000. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26, 97-102.
11. Chida, D., Nakagawa, S., Nagai, S., Sagara, H., Katsumata, H., Imaki, T., Suzuki, H., Mitani, F., Ogishima, T., Shimizu, C., Kotaki, H., Kakuta, S., Sudo, K., Koike, T., Kubo, M., Iwakura, Y., 2007. Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 104, 18205-18210.
12. Chung, T.T., Webb, T.R., Chan, L.F., Cooray, S.N., Metherell, L.A., King, P.J., Chapple, J.P., Clark, A.J., 2008. The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface. J. Clin. Endocrinol. Metab. 93, 4948-4954.
13. Chung, T.T., Chan, L.F., Metherell, L.A., Clark, A.J., 2010. Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2. Clin. Endocrinol. (Oxf) 72, 589-594.
14. Clark, A.J., Weber, A., 1998. Adrenocorticotropin insensitivity syndromes. Endocr. Rev. 19, 828-843.
15. Clark, A.J., McLoughlin, L., Grossman, A., 1993. Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 341, 461-462. (Pubitemid 23054520)
16. Coll, A.P., Challis, B.G., Yeo, G.S., Snell, K., Piper, S.J., Halsall, D., Thresher, R.R., O'Rahilly, S., 2004. The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 145, 4721-4727. (Pubitemid 39281466)
17. Coll, A.P., Fassnacht, M., Klammer, S., Hahner, S., Schulte, D.M., Piper, S., Tung, Y.C., Challis, B.G., Weinstein, Y., Allolio, B., O'Rahilly, S., Beuschlein, F., 2006. Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production. J. Endocrinol. 190, 515-525. (Pubitemid 44288387)
18. Cooray, S.N., Almiro Do Vale, I., Leung, K.Y., Webb, T.R., Chapple, J.P., Egertova, M., Cheetham, M.E., Elphick, M.R., Clark, A.J., 2008. The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse y1 cell line. Endocrinology 149, 1935-1941. (Pubitemid 351468310)
19. Dhillo, W.S., Small, C.J., Gardiner, J.V., Bewick, G.A., Whitworth, E.J., Jethwa, P.H., Seal, L.J., Ghatei, M.A., Hinson, J.P., Bloom, S.R., 2003. Agouti-related protein has an inhibitory paracrine role in the rat adrenal gland. Biochem. Biophys. Res Commun 301, 102-107.
20. Dias, R.P., Chan, L.F., Metherell, L.A., Pearce, S.H., Clark, A.J., 2010. Isolated Addison's disease is unlikely to be caused by mutations in MC2R, MRAP or STAR, three genes responsible for familial glucocorticoid deficiency. Eur. J. Endocrinol. 162, 357-359.
21. Elias, L.L., Huebner, A., Pullinger, G.D., Mirtella, A., Clark, A.J., 1999. Functional characterization of naturally occurring mutations of the human adrenocorticotropin receptor: poor correlation of phenotype and genotype. J. Clin. Endocrinol. Metab. 84, 2766-2770.
22. Elias, L.L., Huebner, A., Metherell, L.A., Canas, A., Warne, G.L., Bitti, M.L., Cianfarani, S., Clayton, P.E., Savage, M.O., Clark, A.J., 2000. Tall stature in familial glucocorticoid deficiency. Clin. Endocrinol. (Oxf) 53, 423-430.
23. Estivariz, F.E., Iturriza, F., McLean, C., Hope, J., Lowry, P.J., 1982. Stimulation of adrenal mitogenesis by N-terminal proopiocortin peptides. Nature 297, 419-422. (Pubitemid 12025095)
24. Estivariz, F.E., Morano, M.I., Carino, M., Jackson, S., Lowry, P.J., 1988. Adrenal regeneration in the rat is mediated by mitogenic N-terminal pro-opiomelanocortin peptides generated by changes in precursor processing in the anterior pituitary. J. Endocrinol. 116, 207-216.
25. Farooqi, I.S., 2008. Monogenic human obesity. Front. Horm. Res. 36, 1-11.
26. Fluck, C.E., Martens, J.W., Conte, F.A., Miller, W.L., 2002. Clinical, genetic, and functional characterization of adrenocorticotropin receptor mutations using a novel receptor assay. J. Clin. Endocrinol. Metab. 87, 4318-4323.
27. Gantz, I., Shimoto, Y., Konda, Y., Miwa, H., Dickinson, C.J., Yamada, T., 1994. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200, 1214-1220.
28. Gardiner, K., Slavov, D., Bechtel, L., Davisson, M., 2002. Annotation of human chromosome 21 for relevance to Down syndrome: gene structure and expression analysis. Genomics 79, 833-843. (Pubitemid 34595318)
29. Genin, E., Huebner, A., Jaillard, C., Faure, A., Halaby, G., Saka, N., Clark, A.J., Durand, P., Begeot, M., Naville, D., 2002. Linkage of one gene for familial glucocorticoid deficiency type 2 (FGD2) to chromosome 8q and further evidence of heterogeneity. Hum. Genet. 111, 428-434.
30. Griffon, N., Mignon, V., Facchinetti, P., Diaz, J., Schwartz, J.C., Sokoloff, P., 1994. Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200, 1007-1014.
31. Hughes, C.R., Chung, T.T., Habeb, A.M., Clark, A.J.L., Metherell, L.A., 2009. Functional characterisation of a missense mutation (p.Y59D) of MRAP which leads to familial glucocorticoid deficiency type 2. 8th Joint Meeting of the Lawson Wilkins Pediatric Endocrine Society/European Society for Paediatric Endocrinology, FC8-048.
32. Imamine, H., Mizuno, H., Sugiyama, Y., Ohro, Y., Sugiura, T., Togari, H., 2005. Possible relationship between elevated plasma ACTH and tall stature in familial glucocorticoid deficiency. Tohoku J. Exp. Med. 205, 123-131.
33. Iwen, K.A., Senyaman, O., Schwartz, A., Drenckhan, M., Meier, B., Hadaschik, D., Klein, J., 2008. Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes. J. Endocrinol. 196, 465-472. (Pubitemid 351425502)
34. Kojima, I., Kojima, K., Rasmussen, H., 1985. Role of calcium and cAMP in the action of adrenocorticotropin on aldosterone secretion. J. Biol. Chem. 260, 4248-4256.
35. Kuwasako, K., Kitamura, K., Nagoshi, Y., Cao, Y.N., Eto, T., 2003. Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity. J. Biol. Chem. 278, 22623-22630.
36. Lappalainen, S., Utriainen, P., Kuulasmaa, T., Voutilainen, R., Jaaskelainen, J., 2008. ACTH receptor promoter polymorphism associates with severity of premature adrenarche and modulates hypothalamo-pituitary-adrenal axis in children. Pediatr. Res. 63, 410-414.
37. Latronico, A.C., Reincke, M., Mendonca, B.B., Arai, K., Mora, P., Allolio, B., Wajchenberg, B.L., Chrousos, G.P., Tsigos, C., 1995. No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. J. Clin. Endocrinol. Metab. 80, 875-877.
38. Le, T., Schimmer, B.P., 2001. The regulation of MAPKs in Y1 mouse adrenocortical tumor cells. Endocrinology 142, 4282-4287. (Pubitemid 32907055)
39. Lebrethon, M.C., Naville, D., Begeot, M., Saez, J.M., 1994. Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II. J. Clin. Invest. 93, 1828-1833.
40. Lein, E.S., Hawrylycz, M.J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A.F., Boguski, M.S., Brockway, K.S., Byrnes, E.J., Chen, L., Chen, T.M., Chin, M.C., Chong, J., Crook, B.E., Czaplinska, A., Dang, C.N., Datta, S., Dee, N.R., Desaki, A.L., Desta, T., Diep, E., Dolbeare, T.A., Donelan, M.J., Dong, H.W., Dougherty, J.G., Duncan, B.J., Ebbert, A.J., Eichele, G., Estin, L.K., Faber, C., Facer, B.A., Fields, R., Fischer, S.R., Fliss, T.P., Frensley, C., Gates, S.N., Glattfelder, K.J., Halverson, K.R., Hart, M.R., Hohmann, J.G., Howell, M.P., Jeung, D.P., Johnson, R.A., Karr, P.T., Kawal, R., Kidney, J.M., Knapik, R.H., Kuan, C.L., Lake, J.H., Laramee, A.R., Larsen, K.D., Lau, C., Lemon, T.A., Liang, A.J., Liu, Y., Luong, L.T., Michaels, J., Morgan, J.J., Morgan, R.J., Mortrud, M.T., Mosqueda, N.F., Ng, L.L., Ng, R., Orta, G.J., Overly, C.C., Pak, T.H., Parry, S.E., Pathak, S.D., Pearson, O.C., Puchalski, R.B., Riley, Z.L., Rockett, H.R., Rowland, S.A., Royall, J.J., Ruiz, M.J., Sarno, N.R., Schaffnit, K., Shapovalova, N.V., Sivisay, T., Slaughterbeck, C.R., Smith, S.C., Smith, K.A., Smith, B.I., Sodt, A.J., Stewart, N.N., Stumpf, K.R., Sunkin, S.M., Sutram, M., Tam, A., Teemer, C.D., Thaller, C., Thompson, C.L., Varnam, L.R., Visel, A., Whitlock, R.M., Wohnoutka, P.E., Wolkey, C.K., Wong, V.Y., Wood, M., Yaylaoglu, M.B., Young, R.C., Youngstrom, B.L., Yuan, X.F., Zhang, B., Zwingman, T.A., Jones, A.R., 2007. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168-176.
41. Light, K., Jenkins, P.J., Weber, A., Perrett, C., Grossman, A., Pistorello, M., Asa, S.L., Clayton, R.N., Clark, A.J., 1995. Are activating mutations of the adrenocorticotropin receptor involved in adrenal cortical neoplasia? Life Sci. 56, 1523-1527.
42. Lin, L., Al-Ali, M., Alzyoud, M., Hindmarsh, P.C., Brain, C.E., Metherell, L., Clark, A.J.L., Dattani, M.T., Achermann, J.C., 2004. Mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be associatedwith disturbed renin-sodiumhomeostasis 23.Horm. Res. 62, 1-215.
43. Lin, L., Hindmarsh, P.C., Metherell, L.A., Alzyoud, M., Al Ali, M., Brain, C.E., Clark, A.J., Dattani, M.T., Achermann, J.C., 2007. Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia. Clin. Endocrinol. (Oxf) 66, 205-210.
44. Lowry, P.J., Silas, L., McLean, C., Linton, E.A., Estivariz, F.E., 1983. Pro-[gamma]-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth. Nature 306, 70-73. (Pubitemid 13022770)
45. Masui, H., Garren, L.D., 1971. Inhibition of replication in functional mouse adrenal tumor cells by adrenocorticotropic hormone mediated by adenosine 3′:5′-cyclic monophosphate. Proc. Natl Acad. Sci. USA 68, 3206-3210.
46. McLatchie, L.M., Fraser, N.J., Main, M.J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M.G., Foord, S.M., 1998. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393, 333-339. (Pubitemid 28269699)
47. Metherell, L.A., Chapple, J.P., Cooray, S., David, A., Becker, C., Ruschendorf, F., Naville, D., Begeot, M., Khoo, B., Nurnberg, P., Huebner, A., Cheetham, M.E., Clark, A.J., 2005. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat. Genet. 37, 166-170.
48. Metherell, L.A., Naville, D., Halaby, G., Begeot, M., Huebner, A., Nurnberg, G., Nurnberg, P., Green, J., Tomlinson, J.W., Krone, N.P., Lin, L., Racine, M., Berney, D.M., Achermann, J.C., Arlt, W., Clark, A.J., 2009. Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. J. Clin. Endocrinol. Metab. 94, 3865-3871.
49. Modan-Moses, D., Ben-Zeev, B., Hoffmann, C., Falik-Zaccai, T.C., Bental, Y.A., Pinhas-Hamiel, O., Anikster, Y., 2006. Unusual presentation of familial glucocorticoid deficiency with a novel MRAP mutation. J. Clin. Endocrinol. Metab. 91, 3713-3717.
50. Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., Cone, R.D., 1992. The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251.
51. Mountjoy, K.G., Bird, I.M., Rainey, W.E., Cone, R.D., 1994. ACTH induces up-regulation of ACTH receptor mRNA in mouse and human adrenocortical cell lines. Mol. Cell. Endocrinol. 99, R17-R20.
52. Mountjoy, K.G., Jenny Wu, C.S., Dumont, L.M., Wild, J.M., 2003. Melanocortin-4 receptor messenger ribonucleic acid expression in rat cardiorespiratory, musculoskeletal, and integumentary systems. Endocrinology 144, 5488-5496. (Pubitemid 37476078)
53. Naville, D., Penhoat, A., Barjhoux, L., Jaillard, C., Fontanay, S., Saez, J., Durand, P., Begeot, M., 1996. Characterization of the human ACTH receptor gene and in vitro expression. Endocr. Res. 22, 337-348.
54. Naville, D., Barjhoux, L., Jaillard, C., Saez, J.M., Durand, P., Begeot, M., 1997. Stable expression of normal and mutant human ACTH receptor: study of ACTH binding and coupling to adenylate cyclase. Mol. Cell. Endocrinol. 129, 83-90.
55. Naville, D., Penhoat, A., Durand, P., Begeot, M., 1999. Three steroidogenic factor-1 binding elements are required for constitutive and cAMP-regulated expression of the human adrenocorticotropin receptor gene. Biochem. Biophys. Res. Commun. 255, 28-33.
56. Nimura, M., Udagawa, J., Hatta, T., Hashimoto, R., Otani, H., 2006. Spatial and temporal patterns of expression of melanocortin type 2 and 5 receptors in the fetal mouse tissues and organs. Anat. Embryol. 211, 109-117.
57. Noon, L.A., Franklin, J.M., King, P.J., Goulding, N.J., Hunyady, L., Clark, A.J., 2002. Failed export of the adrenocorticotrophin receptor from the endoplasmic reticulum in non-adrenal cells: evidence in support of a requirement for a specific adrenal accessory factor. J. Endocrinol. 174, 17-25. (Pubitemid 34830929)
58. O'Riordan, S.M., Lynch, S.A., Hindmarsh, P.C., Chan, L.F., Clark, A.J., Costigan, C., 2008. A novel variant of familial glucocorticoid deficiency prevalent among the Irish Traveler population. J. Clin. Endocrinol. Metab. 93, 2896-2899.
59. Parameswaran, N., Spielman, W.S., 2006. RAMPs: the past, present and future. Trends Biochem. Sci. 31, 631-638.
60. Payet, N., Lehoux, J.G., 1980. A comparative study of the role of vasopressin and ACTH in the regulation of growth and function of rat adrenal glands. J. Steroid Biochem. 12, 461-467. (Pubitemid 10075372)
61. Plotsky, P.M., 1988. Hypophysiotropic regulation of stress-induced ACTH secretion. Adv. Exp. Med. Biol. 245, 65-81.
62. Ramachandran, J., Suyama, A.T., 1975. Inhibition of replication of normal adrenocortical cells in culture by adrenocorticotropin. Proc. Natl Acad. Sci. USA 72, 113-117.
63. Reincke, M., Mora, P., Beuschlein, F., Arlt, W., Chrousos, G.P., Allolio, B., 1997. Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: implications for tumorigenesis. J. Clin. Endocrinol. Metab. 82, 3054-3058.
64. Reincke, M., Beuschlein, F., Menig, G., Hofmockel, G., Arlt, W., Lehmann, R., Karl, M., Allolio, B., 1998. Localization and expression of adrenocorticotropic hormone receptor mRNA in normal and neoplastic human adrenal cortex. J. Endocrinol. 156, 415-423. (Pubitemid 28131458)
65. Reisch, N., Slawik, M., Zwermann, O., Beuschlein, F., Reincke, M., 2005. Genetic influence of an ACTH receptor promoter polymorphism on adrenal androgen secretion. Eur. J. Endocrinol. 153, 711-715.
66. Robinson, P.M., Comline, R.S., Fowden, A.L., Silver, M., 1983. Adrenal cortex of fetal lamb: changes after hypophysectomy and effects of Synacthen on cytoarchitecture and secretory activity. Q. J. Exp. Physiol. 68, 15-27.
67. Roy, S., Rached, M., Gallo-Payet, N., 2007. Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms alpha and beta in isogenic human embryonic kidney 293 cells. Mol. Endocrinol. 21, 1656-1669.
68. Rumie, H., Metherell, L.A., Clark, A.J., Beauloye, V., Maes, M., 2007. Clinical and biological phenotype of a patient with familial glucocorticoid deficiency type 2 caused by a mutation of melanocortin 2 receptor accessory protein. Eur. J. Endocrinol. 157, 539-542.
69. Saito, H., Kubota, M., Roberts, R.W., Chi, Q., Matsunami, H., 2004. RTP family members induce functional expression of mammalian odorant receptors. Cell 119, 679-691. (Pubitemid 39535755)
70. Sawchenko, P.E., Swanson, L.W., 1985. Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed. Proc. 44, 221-227.
71. Schioth, H.B., Muceniece, R., Larsson, M., Mutulis, F., Szardenings, M., Prusis, P., Lindeberg, G., Wikberg, J.E., 1997. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. Eur. J. Pharmacol. 319, 369-373.
72. Sebag, J.A., Hinkle, P.M., 2007. Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers. Proc. Natl Acad. Sci. USA 104, 20244-20249.
73. Sebag, J.A., Hinkle, P.M., 2009a. Opposite effects of the melanocortin-2 (MC2) receptor accessory protein MRAP on MC2 and MC5 receptor dimerization and trafficking. J. Biol. Chem. 284, 22641-22648.
74. Sebag, J.A., Hinkle, P.M., 2009b. Regions of melanocortin 2 (MC2) receptor accessory protein necessary for dual topology and MC2 receptor trafficking and signaling. J. Biol. Chem. 284, 610-618.
75. Sebag, J.A., Hinkle, P.M., 2010. Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2. Sci. Signal. 3, ra28.
76. Selva, K.A., Lafranchi, S.H., Boston, B., 2004. A novel presentation of familial glucocorticoid deficiency (FGD) and current literature review. J. Pediatr. Endocrinol. Metab. 17, 85-92.
77. Shepard, T., Landing, B., Mason, D., 1959. Familial Addison's disease; case reports of two sisters with cortisol deficiency unassociated with hypoaldosteronism. AMA J. Dis. Child 97, 154-162.
78. Slawik, M., Reisch, N., Zwermann, O., Maser-Gluth, C., Stahl, M., Klink, A., Reincke, M., Beuschlein, F., 2004. Characterization of an adrenocorticotropin (ACTH) receptor promoter polymorphism leading to decreased adrenal responsiveness to ACTH. J. Clin. Endocrinol. Metab. 89, 3131-3137.
79. Smart, J.L., Low, M.J., 2003. Lack of proopiomelanocortin peptides results in obesity and defective adrenal function but normal melanocyte pigmentation in the murine C57BL/6 genetic background. Ann. N. Y. Acad. Sci. 994, 202-210.
80. Suda, T., Yajima, F., Tomori, N., Sumitomo, T., Nakagami, Y., Ushiyama, T., Demura, H., Shizume, K., 1986. Inhibitory effect of adrenocorticotropin on corticotropin- releasing factor release from rat hypothalamus in vitro. Endocrinology 118, 459-461. (Pubitemid 16147594)
81. Suda, T., Tomori, N., Yajima, F., Ushiyama, T., Sumitomo, T., Nakagami, Y., Demura, H., Shizume, K., 1987. A short negative feedback mechanism regulating corticotropin-releasing hormone release. J. Clin. Endocrinol. Metab. 64, 909-913.
82. Swords, F.M., Baig, A., Malchoff, D.M., Malchoff, C.D., Thorner, M.O., King, P.J., Hunyady, L., Clark, A.J., 2002. Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity. Mol. Endocrinol. 16, 2746-2753.
83. Tsigos, C., Arai, K., Hung, W., Chrousos, G.P., 1993. Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene. J. Clin. Invest. 92, 2458-2461.
84. Tsiotra, P.C., Koukourava, A., Kaltezioti, V., Geffner, M.E., Naville, D., Begeot, M., Raptis, S.A., Tsigos, C., 2006. Compound heterozygosity of a frameshift mutation in the coding region and a single base substitution in the promoter of the ACTH receptor gene in a family with isolated glucocorticoid deficiency. J. Pediatr. Endocrinol. Metab. 19, 1157-1166.
85. van der Kraan, M., Adan, R.A., Entwistle, M.L., Gispen, W.H., Burbach, J.P., Tatro, J.B., 1998. Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology 139, 2348-2355. (Pubitemid 28513758)
86. Vinson, G.P., Whitehouse, B.J., Dell, A., Etienne, T., Morris, H.R., 1980. Characterisation of an adrenal zona glomerulosa-stimulating component of posterior pituitary extracts as alpha-MSH. Nature 284, 464-467. (Pubitemid 10121325)
87. Webb, T.R., Clark, A.J., 2010. Minireview: the melanocortin 2 receptor accessory proteins. Mol. Endocrinol. 24, 475-484.
88. Webb, T.R., Chan, L., Cooray, S.N., Cheetham, M.E., Chapple, J.P., Clark, A.J., 2009. Distinct melanocortin 2 receptor accessory protein domains are required for melanocortin 2 receptor interaction and promotion of receptor trafficking. Endocrinology 150, 720-726.
89. Weber, A., Toppari, J., Harvey, R.D., Klann, R.C., Shaw, N.J., Ricker, A.T., Nanto-Salonen, K., Bevan, J.S., Clark, A.J., 1995. Adrenocorticotropin receptor gene mutations in familial glucocorticoid deficiency: relationships with clinical features in four families. J. Clin. Endocrinol. Metab. 80, 65-71.
90. Weber, A., Clark, A.J., Perry, L.A., Honour, J.W., Savage, M.O., 1997. Diminished adrenal androgen secretion in familial glucocorticoid deficiency implicates a significant role for ACTH in the induction of adrenarche. Clin. Endocrinol. (Oxf) 46, 431-437.
91. Wikberg, J.E.S., 1999. Melanocortin receptors: perspectives for novel drugs. Eur. J. Pharmacol. 375, 295-310.
92. Xu, A., Choi, K.L., Wang, Y., Permana, P.A., Xu, L.Y., Bogardus, C., Cooper, G.J., 2002. Identification of novel putative membrane proteins selectively expressed during adipose conversion of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 293, 1161-1167.
93. Yaswen, L., Diehl, N., Brennan, M.B., Hochgeschwender, U., 1999. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 5, 1066-1070.
94. Zhong, Q., Sridhar, S., Ruan, L., Ding, K.H., Xie, D., Insogna, K., Kang, B., Xu, J., Bollag, R.J., Isales, C.M., 2005. Multiple melanocortin receptors are expressed in bone cells. Bone 36, 820-831. (Pubitemid 40616017)